Pharmacy

The primary symptom or concern reported by the patient at the time of a clinical encounter related to an adverse reaction event, documented in the patient's own words or clinician summary. Used in triage, clinical notes, and encounter records to establish the presenting reason for care.

A subordinate or linked reaction record associated with a parent adverse reaction entry in a hierarchical data structure. Used in clinical data systems to represent component-level reaction details, secondary responses, or related events that are nested under a primary reaction documentation record.

The municipality or city name associated with the location where a documented adverse reaction event occurred or where the patient resides. Used in public health surveillance, pharmacovigilance reporting, and geographic analysis of adverse reaction patterns across clinical and claims data systems.

The classification tier assigned to a documented adverse reaction based on its type, mechanism, or severity level, such as immunologic, pharmacologic, or idiosyncratic. Used in allergy management systems and clinical decision support tools to guide treatment protocols and contraindication alerts.

A standardized alphanumeric code used to identify and classify a specific adverse reaction or allergic response within clinical data systems, often derived from coding terminologies such as SNOMED CT, MedDRA, or local EHR catalogs. Enables consistent cross-system tracking, reporting, and clinical decision support.

The dollar amount a member is responsible for paying as a percentage of covered costs associated with treatment of a documented adverse reaction. Used in claims adjudication to calculate member cost-sharing obligations after the deductible has been met for reaction-related services.

Free-text field capturing clinician notes, observations, or supplemental details about a documented adverse reaction recorded in the patient medical record. May include descriptions of symptom onset, severity context, clinical interventions taken, or follow-up instructions related to the reaction event.

The calendar date on which documentation, treatment, or clinical follow-up for a recorded adverse reaction was marked as complete. Used in clinical workflows to track resolution timelines and ensure all reaction-related care episodes are fully documented within the patient health record.

A flag that designates whether a documented adverse reaction record contains sensitive information requiring restricted access within clinical systems. When set, this indicator limits visibility of the reaction details to authorized users only, supporting patient privacy and compliance with applicable data protection regulations.

The fixed dollar amount a member is required to pay at the point of service for treatment directly associated with a documented adverse reaction. Used in pharmacy and medical claims processing to record the member's flat-fee cost-sharing responsibility separate from coinsurance or deductible obligations.

The total expense incurred for clinical management, treatment, or documentation of a recorded adverse reaction. Used in healthcare cost analytics and claims data to assess financial impact of reaction-related care, including medications, emergency visits, or specialist consultations tied to the reaction event.

A numeric value representing the total number of adverse reaction events recorded for a patient, substance, or clinical encounter within a defined period. Used in pharmacovigilance, allergy management, and population health reporting to identify patients with multiple or recurring reaction histories.

The country in which an adverse reaction event was reported or occurred. Used in pharmacovigilance and adverse event surveillance systems to support geographic tracking of drug or substance reactions, regulatory reporting requirements, and cross-border safety signal monitoring.

The unique identifier of the clinician, staff member, or system user who originally entered the adverse reaction record into the clinical or administrative system. Used for audit trail purposes and accountability tracking within electronic health records and adverse event reporting workflows.

The calendar date on which an adverse reaction record was first entered or created in the clinical system. Used for audit trail maintenance, workflow tracking, and regulatory reporting to establish when a reaction was initially documented relative to the actual date of the reaction event.

The timestamp indicating the exact time at which an adverse reaction record was first entered into the clinical or administrative system. Used alongside the created date for precise audit trail logging, workflow sequencing, and compliance reporting in adverse event management systems.

The serum or urine creatinine measurement recorded in association with an adverse reaction event, used to assess renal function impact. Elevated creatinine values may indicate nephrotoxic reactions to medications or contrast agents and inform clinical decision-making regarding treatment adjustment or discontinuation.

The calendar date on which a patient experienced or first reported an adverse reaction to a drug, substance, or clinical intervention. Used in allergy and adverse event records to establish the clinical timeline, assess causality, and support longitudinal tracking of reaction history across care episodes.

The combined date and time value recording the precise moment a patient experienced or reported an adverse reaction. Used in clinical documentation, pharmacovigilance systems, and adverse event tracking to establish an accurate temporal sequence for reaction onset, clinical response, and treatment intervention.

The Drug Enforcement Administration registration number associated with the prescribing clinician or dispensing pharmacy linked to a documented adverse reaction. Used to identify the controlled substance prescriber or dispenser involved in a reaction event for regulatory reporting and accountability tracking purposes.